Bispebjerg Hospital
Copenhagen, 2400, Denmark
NCT Number: NCT03571074
Several studies show how patients with hyperoxia after cardiac arrest has increased mortality, but the association of hyperoxia before cardiac arrest and myocardial damage has never been investigated. Neither has the association between hyperoxia after cardiac arrest and myocardial injury.
Our research hypothesis is that hyperoxia before cardiac arrest aggravates myocardial damage, secondly we wish to analyze the association between hyperoxia after cardiac arrest and myocardial injury.
The exposure variables is oxygenation within 48 hours before and 48 hours after cardiac arrest, our primary outcome is myocardial damage and will be measured as peak troponin within 30 days after cardiac arrest.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen, 2400, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oxygenation measured as oxygen supply and saturation before cardiac arrest, and oxygenation measured as PaO2 after cardiac arrest.
Time frame: 30 days
Troponin measurements on patients after cardiac arrest.
Time frame: Up to 1 year.
Time frame: 3 days
Time frame: through study completion,on average of 4-8 weeks.
Time frame: through study completion,on average of 4-8 weeks.
University Hospital Bispebjerg and Frederiksberg
Other
Hyperoxia Before and After Cardiac Arrest and Myocardial Damage, a Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06836908
Cardiac Arrest, Cardiovascular Diseases
Vienna, Austria
View Trial DetailsNCT05756621
Cardiac Arrest, Cardiovascular Diseases
Brescia, BS, Italy
View Trial DetailsNCT02527031
Cardiac Arrest, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT03817892
Cardiac Arrest, Cardiopulmonary Resuscitation
Caen, Normandy, France
View Trial Details